Cedilla Therapeutics

Cedilla Therapeutics

Biotechnology, 38 Sidney St Ste 200, Cambridge, Massachusetts, 02139, United States, 11-50 Employees

cedillatx.com

  • twitter
  • LinkedIn

phone no Phone Number: 92********

Who is CEDILLA THERAPEUTICS

For 60 years, sequence and structure has been the primary lens to understand protein function. Its now time to look beyond and leverage the orchestration of protein function within cells....

Read More

map
  • 38 Sidney St Ste 200, Cambridge, Massachusetts, 02139, United States Headquarters: 38 Sidney St Ste 200, Cambridge, Massachusetts, 02139, United States
  • 2018 Date Founded: 2018
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $5 Million to $10 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from CEDILLA THERAPEUTICS

Cedilla Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Cedilla Therapeutics

Answer: Cedilla Therapeutics's headquarters are located at 38 Sidney St Ste 200, Cambridge, Massachusetts, 02139, United States

Answer: Cedilla Therapeutics's phone number is 92********

Answer: Cedilla Therapeutics's official website is https://cedillatx.com

Answer: Cedilla Therapeutics's revenue is $5 Million to $10 Million

Answer: Cedilla Therapeutics's SIC: 2834

Answer: Cedilla Therapeutics has 11-50 employees

Answer: Cedilla Therapeutics is in Biotechnology

Answer: Cedilla Therapeutics contact info: Phone number: 92******** Website: https://cedillatx.com

Answer: For 60 years, sequence and structure has been the primary lens to understand protein function. Its now time to look beyond and leverage the orchestration of protein function within cells. Cedilla Therapeutics is bringing a new dimension to precision oncology. We have discovered new ways to selectively inhibit oncogenic drivers with small molecules that conditionally modulate proteins in their functional state. Our conditional inhibitors are unlocking critical and elusive cancer targets including TEAD and CDK2. We are a driven and patient-focused team.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access